Literature DB >> 2668914

Synthesis of palmitoyl derivatives of insulin and their biological activities.

M Hashimoto1, K Takada, Y Kiso, S Muranishi.   

Abstract

In order to improve the lipophilicity of peptides, bovine insulin was chosen for the chemical modification using palmitic acid. The N-hydroxysuccinimide ester of palmitic acid was used for attachment to terminal amino groups, and p-methoxybenzoxycarbonyl azide was used for protection of the glycine-A1 amino terminus. We obtained two purified derivatives of insulin, B1-monopalmitoyl- and B1,B29-dipalmitoyl-insulin, which were confirmed to be more lipophilic than the parent insulin on high-performance liquid chromatography (HPLC). The hypoglycemic effects of both products were measured in rats after intravenous and intramuscular injections. The mono derivative was more active than the di derivative and produced a longer effect duration than the native insulin after intravenous injection. The derivatives were also shown to be less immunoreactive as judged by an enzyme immunoassay.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2668914     DOI: 10.1023/a:1015992828666

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  7 in total

1.  Molecular basis of insulin action: contributions of chemical modifications and synthetic approaches.

Authors:  H Zahn; D Brandenburg; H G Gattner
Journal:  Diabetes       Date:  1972       Impact factor: 9.461

2.  Interference in glucose oxidase-peroxidase blood glucose methods.

Authors:  P Sharp
Journal:  Clin Chim Acta       Date:  1972-08       Impact factor: 3.786

3.  An enzyme immunoassay system for measurements of serum insulin.

Authors:  H Shinkai; M Sohma; Y Takahashi; R Kojima; M Hashimoto; N Ogawa
Journal:  Mol Immunol       Date:  1980-03       Impact factor: 4.407

4.  Use of esters of N-hydroxysuccinimide in the synthesis of N-acylamino acids.

Authors:  Y Lapidot; S Rappoport; Y Wolman
Journal:  J Lipid Res       Date:  1967-03       Impact factor: 5.922

5.  Biotinylinsulins as potential tools for receptor studies.

Authors:  K Hofmann; F M Finn; H J Friesen; C Diaconescu; H Zahn
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

6.  The acetylation of insulin.

Authors:  D G Lindsay; S Shall
Journal:  Biochem J       Date:  1971-03       Impact factor: 3.857

7.  Acetoacetylation of insulin.

Authors:  D G Lindsay; S Shall
Journal:  Biochem J       Date:  1969-11       Impact factor: 3.857

  7 in total
  18 in total

1.  NB1-C16-insulin: site-specific synthesis, purification, and biological activity.

Authors:  H Mei; C Yu; K K Chan
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

Review 2.  New technologies for drug delivery across the blood brain barrier.

Authors:  A V Kabanov; E V Batrakova
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

3.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

Review 4.  Stability of protein pharmaceuticals.

Authors:  M C Manning; K Patel; R T Borchardt
Journal:  Pharm Res       Date:  1989-11       Impact factor: 4.200

5.  Preparation, purification, and characterization of a reversibly lipidized desmopressin with potentiated anti-diuretic activity.

Authors:  J Wang; D Shen; W C Shen
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

6.  Development of new lipophilic derivatives of tetragastrin: physicochemical characteristics and intestinal absorption of acyl-tetragastrin derivatives in rats.

Authors:  T Tenma; E Yodoya; S Tashima; T Fujita; M Murakami; A Yamamoto; S Muranishi
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

7.  Stability of acyl derivatives of insulin in the small intestine: relative importance of insulin association characteristics in aqueous solution.

Authors:  H Asada; T Douen; Y Mizokoshi; T Fujita; M Murakami; A Yamamoto; S Muranishi
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

8.  Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations.

Authors:  Z Shao; R Krishnamoorthy; A K Mitra
Journal:  Pharm Res       Date:  1992-09       Impact factor: 4.200

Review 9.  Fatty acids as therapeutic auxiliaries for oral and parenteral formulations.

Authors:  Michael J Hackett; Jennica L Zaro; Wei-Chiang Shen; Patrick C Guley; Moo J Cho
Journal:  Adv Drug Deliv Rev       Date:  2012-08-17       Impact factor: 15.470

10.  Protein and Peptide drug delivery: oral approaches.

Authors:  Jessy Shaji; V Patole
Journal:  Indian J Pharm Sci       Date:  2008 May-Jun       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.